Adverse driving behaviors increase over time as a function of preclinical Alzheimer's disease biomarkers

We investigated the relationship between preclinical Alzheimer's disease (AD) biomarkers and adverse driving behaviors in a longitudinal analysis of naturalistic driving data.

[1]  J. Morris,et al.  Neuropsychological correlates of changes in driving behavior among clinically healthy older adults. , 2022, The journals of gerontology. Series B, Psychological sciences and social sciences.

[2]  A. Fagan,et al.  Adverse driving behaviors are associated with sleep apnea severity and age in cognitively normal older adults at risk for Alzheimer's disease. , 2022, Sleep.

[3]  A. Fagan,et al.  Correspondence of CSF biomarkers measured by Lumipulse assays with amyloid PET , 2021, Alzheimer's & Dementia.

[4]  J. Morris,et al.  COVID‐19 and preclinical Alzheimer disease: Driving, mobility, activity and experiences of older adults in the United States , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[5]  A. Fagan,et al.  Identifying preclinical Alzheimer disease from driving patterns: A machine learning approach , 2021, Alzheimer's & Dementia.

[6]  A. Fagan,et al.  GPS driving: a digital biomarker for preclinical Alzheimer disease , 2021, Alzheimer's research & therapy.

[7]  Christopher B. Rosnick,et al.  Reaction to a Pandemic: Social Distancing and Driving Among Older Adults During COVID-19 , 2020, Journal of applied gerontology : the official journal of the Southern Gerontological Society.

[8]  R. Irizarry.  ggplot2 , 2019, Introduction to Data Science.

[9]  Rafik Goubran,et al.  Trip-Based Measures of Naturalistic Driving: Considerations and Connections With Cognitive Status in Older Adult Drivers , 2019, IEEE Transactions on Instrumentation and Measurement.

[10]  Jennifer D. Davis,et al.  A 2.5-Year Longitudinal Assessment of Naturalistic Driving in Preclinical Alzheimer's Disease. , 2019, Journal of Alzheimer's disease : JAD.

[11]  J. Morris,et al.  A Naturalistic Study of Driving Behavior in Older Adults and Preclinical Alzheimer Disease: A Pilot Study , 2019, Journal of applied gerontology : the official journal of the Southern Gerontological Society.

[12]  Brian A. Gordon,et al.  Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease , 2018, Neurology.

[13]  Daniel Lüdecke,et al.  ggeffects: Tidy Data Frames of Marginal Effects from Regression Models , 2018, J. Open Source Softw..

[14]  Stewart G. Armitage,et al.  An Analysis of Certain Psychological Tests Used for the Evaluation of Brain Injury , 2017 .

[15]  Brian C. Tefft,et al.  Rates of Motor Vehicle Crashes, Injuries and Deaths in Relation to Driver Age, United States, 2014-2015 , 2017 .

[16]  Chengjie Xiong,et al.  Preclinical Alzheimer's disease and longitudinal driving decline , 2016, Alzheimer's & dementia.

[17]  Brian R. Ott,et al.  Brain amyloid in preclinical Alzheimer's disease is associated with increased driving risk , 2016, Alzheimer's & Dementia.

[18]  C. Roe,et al.  Development and interval testing of a naturalistic driving methodology to evaluate driving behavior in clinical research , 2016, F1000Research.

[19]  T. Scalea,et al.  Are frailty markers associated with serious thoracic and spinal injuries among motor vehicle crash occupants? , 2016, The journal of trauma and acute care surgery.

[20]  D. Y. Lee,et al.  Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. , 2015, JAMA.

[21]  D. Bates,et al.  Fitting Linear Mixed-Effects Models Using lme4 , 2014, 1406.5823.

[22]  Lisa J Molnar,et al.  Reprint of "Driving avoidance by older adults: Is it always self-regulation?". , 2013, Accident; analysis and prevention.

[23]  Lisa J Molnar,et al.  Tactical, strategic, and life-goal self-regulation of driving by older adults: development and testing of a questionnaire. , 2013, Journal of safety research.

[24]  C. Jack,et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.

[25]  A. Fagan,et al.  Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease. , 2009, Archives of neurology.

[26]  Lesley A Ross,et al.  Driving status and three-year mortality among community-dwelling older adults. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[27]  Thomas A. Dingus,et al.  Comparing Real-World Behaviors of Drivers with High Versus Low Rates of Crashes and Near Crashes , 2009 .

[28]  S. Marshall.  The Role of Reduced Fitness to Drive Due to Medical Impairments in Explaining Crashes Involving Older Drivers , 2008, Traffic injury prevention.

[29]  P. Thomann,et al.  Increased tau protein differentiates mild cognitive impairment from geriatric depression and predicts conversion to dementia , 2007, Neuroscience Letters.

[30]  Geri Adler,et al.  Older Adults' Perspectives on Driving Cessation , 2006 .

[31]  Gina N. LaRossa,et al.  Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans , 2006, Annals of neurology.

[32]  Dale Andrea,et al.  Influence of chronic illness on crash involvement of motor vehicle drivers: 2nd edition , 2010 .

[33]  A. Dale,et al.  Whole Brain Segmentation Automated Labeling of Neuroanatomical Structures in the Human Brain , 2002, Neuron.

[34]  Stephanie J. Fonda,et al.  Changes in driving patterns and worsening depressive symptoms among older adults. , 2001, The journals of gerontology. Series B, Psychological sciences and social sciences.

[35]  L J Cook,et al.  Motor vehicle crash characteristics and medical outcomes among older drivers in Utah, 1992-1995. , 2000, Annals of emergency medicine.

[36]  A. Dale,et al.  Cortical Surface-Based Analysis II: Inflation, Flattening, and a Surface-Based Coordinate System , 1999, NeuroImage.

[37]  T. Tombaugh,et al.  Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. , 1999, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[38]  Daniel H. Mathalon,et al.  Correction for head size in brain-imaging measurements , 1993, Psychiatry Research: Neuroimaging.

[39]  A. Fagan,et al.  Amyloid Imaging, Cerebrospinal Fluid Biomarkers Predict Driving Performance Among Cognitively Normal Individuals , 2017, Alzheimer disease and associated disorders.